CID 67424139

Sorafenib metabolite m3

Structural Information

Molecular Formula
C21H16ClF3N4O4
SMILES
C1=CC(=CC=C1NC(=O)NC2=CC(=C(C=C2)Cl)C(F)(F)F)OC3=CC(=NC=C3)C(=O)NCO
InChI
InChI=1S/C21H16ClF3N4O4/c22-17-6-3-13(9-16(17)21(23,24)25)29-20(32)28-12-1-4-14(5-2-12)33-15-7-8-26-18(10-15)19(31)27-11-30/h1-10,30H,11H2,(H,27,31)(H2,28,29,32)
InChIKey
HCXYKSDRIWQAMU-UHFFFAOYSA-N
Compound name
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-(hydroxymethyl)pyridine-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

6
Patents

480.0812 Da
Monoisotopic Mass

3.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 481.08848 205.3
[M+Na]+ 503.07042 211.5
[M-H]- 479.07392 208.8
[M+NH4]+ 498.11502 210.5
[M+K]+ 519.04436 205.3
[M+H-H2O]+ 463.07846 192.9
[M+HCOO]- 525.07940 218.8
[M+CH3COO]- 539.09505 237.5
[M+Na-2H]- 501.05587 207.6
[M]+ 480.08065 204.2
[M]- 480.08175 204.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe